Joun Park1, Yi Zhu2, Xianzun Tao3, Jennifer M Brazill2, Chong Li4, Stefan Wuchty5, R Grace Zhai6. 1. Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA; Program in Neuroscience, University of Miami Miller School of Medicine, Miami, FL 33136, USA. 2. Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA; Program in Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA. 3. Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA. 4. Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA; Program in Human Genetics and Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA. 5. Department of Computer Science, University of Miami, Coral Gables, FL 33146, USA. 6. Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA; Program in Neuroscience, University of Miami Miller School of Medicine, Miami, FL 33136, USA; Program in Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA; Program in Human Genetics and Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Electronic address: gzhai@med.miami.edu.
Abstract
Understanding endogenous regulation of stress resistance and homeostasis maintenance is critical to developing neuroprotective therapies. Nicotinamide mononucleotide adenylyltransferase (NMNAT) is a conserved essential enzyme that confers extraordinary protection and stress resistance in many neurodegenerative disease models. Drosophila Nmnat is alternatively spliced to two mRNA variants, RA and RB. RB translates to protein isoform PD with robust protective activity and is upregulated upon stress to confer enhanced neuroprotection. The mechanisms regulating the alternative splicing and stress response of NMNAT remain unclear. We have discovered a Drosophila microRNA, dme-miR-1002, which promotes the splicing of NMNAT pre-mRNA to RB by disrupting a pre-mRNA stem-loop structure. NMNAT pre-mRNA is preferentially spliced to RA in basal conditions, whereas miR-1002 enhances NMNAT PD-mediated stress protection by binding via RISC component Argonaute1 to the pre-mRNA, facilitating the splicing switch to RB. These results outline a new process for microRNAs in regulating alternative splicing and modulating stress resistance.
Understanding endogenous regulation of stress resistance and homeostasis maintenance is critical to developing neuroprotective therapies. Nicotinamide mononucleotide adenylyltransferase (NMNAT) is a conserved essential enzyme that confers extraordinary protection and stress resistance in many neurodegenerative disease models. DrosophilaNmnat is alternatively spliced to two mRNA variants, RA and RB. RB translates to protein isoform PD with robust protective activity and is upregulated upon stress to confer enhanced neuroprotection. The mechanisms regulating the alternative splicing and stress response of NMNAT remain unclear. We have discovered a Drosophila microRNA, dme-miR-1002, which promotes the splicing of NMNAT pre-mRNA to RB by disrupting a pre-mRNA stem-loop structure. NMNAT pre-mRNA is preferentially spliced to RA in basal conditions, whereas miR-1002 enhances NMNATPD-mediated stress protection by binding via RISC component Argonaute1 to the pre-mRNA, facilitating the splicing switch to RB. These results outline a new process for microRNAs in regulating alternative splicing and modulating stress resistance.
Neuronal stress resistance is a critical component of health and activity. For many animals, neurons produced during development cannot be replaced and must last for the lifetime of the organism (Asatryan and Bazan, 2017). These neurons withstand a plethora of cellular stressors to maintain viability in the face of disease (Orsini et al., 2016), environmental afflictions (Kagias et al., 2012, Kim and Jin, 2015, Saxena and Caroni, 2011), and aging (Chandra et al., 2017, Chandran et al., 2017, Kirkwood, 2003). Understanding how neurons combat stress has wide-ranging implications for organismal health and quality of life.Nicotinamide mononucleotide adenylyltransferase (NMNAT) is a housekeeping enzyme responsible for the synthesis of nicotinamide adenine dinucleotide (NAD+) in all living organisms (Zhai et al., 2009). In addition, NMNAT proteins are essential for neuronal maintenance and protection (Ali et al., 2012, Brazill et al., 2017, Fang et al., 2012, Kitaoka et al., 2013, Press and Milbrandt, 2008, Rossi et al., 2018, Sasaki and Milbrandt, 2010, Sasaki et al., 2009, Wen et al., 2011, Yan et al., 2010, Zhai et al., 2006, Zhai et al., 2008). NMNAT has been shown to confer robust resistance against various stressors across many species, including hypoxia (Ali et al., 2011, Wen et al., 2013), heat (Ali et al., 2011), oxidative stress (Chiurchiù et al., 2016, Cobley et al., 2018), disease states (Ali et al., 2012, Rossi et al., 2018, Ruan et al., 2015, Zhai et al., 2008), and aging (Liu et al., 2018).Humans have three nonredundant Nmnat genes, whereas Drosophila melanogaster has a single Nmnat gene (Ali et al., 2013) that is alternatively spliced into two distinct mRNA variants, RA and RB, giving rise to protein isoforms PC and PD, respectively (Ruan et al., 2015). Isoforms PC and PD share similar biochemical properties but have distinct subcellular localizations and divergent neuroprotective functions; isoform PD is cytosolic and a better neuroprotector than the RA-translated nuclear PC isoform (Ruan et al., 2015). A heat shock response element has been identified in the promoter of DrosophilaNmnat, allowing transcriptional upregulation of NMNAT pre-mRNA during stress conditions by stress transcription factor Heat Shock Factor (HSF) (Ali et al., 2011). Although NMNAT pre-mRNA is slightly preferentially spliced to RA during basal conditions, it has been shown that the splicing of NMNAT pre-mRNA is shifted to RB in response to stress. Even though NMNAT pre-mRNA transcription is upregulated, only NMNAT splice variant RB is increased in stress conditions. Thus, a post-transcriptional “switch” is activated to promote the splicing of NMNAT pre-mRNA to RB and to serve as an effective homeostasis strategy to increase the production of the more protective protein PD isoform under stress (Ruan et al., 2015). However, the identity of the “switch” and the mechanism of regulating NMNAT pre-mRNA alternative splicing under stress remain unknown.MicroRNAs are short (∼22 nt) noncoding RNAs involved in mRNA regulation (Carthew et al., 2017, Chawla et al., 2016). MicroRNAs typically bind complementary nucleotide sequences in the 3′ UTR of target mRNAs through the RNA-induced silencing complex (RISC) (O'Brien et al., 2018), which results in the degradation or translational repression of their targets (Gebert and MacRae, 2018). DrosophilaArgonaute 1, the homolog of mammalianArgonaute 2, is the major RISC component onto which microRNAs are loaded (Yang et al., 2014). Although the vast majority of microRNA-target interactions result in decreased translation of the target, there are some reports of microRNAs upregulating translation of their target mRNAs (Cordes et al., 2009, Ghosh et al., 2008, Jopling et al., 2005, Lu et al., 2010, Mortensen et al., 2011, Ørom et al., 2008, Tsai et al., 2009, Vasudevan et al., 2007), often through binding the 5′UTR (Jopling et al., 2005, Ørom et al., 2008, Tsai et al., 2009). In addition, microRNAs have been implicated in stress response (Edeleva and Shcherbata, 2013, Matsuzaki and Ochiya, 2018, Münzel and Daiber, 2017, Wu et al., 2011) and homeostasis (Bijkerk et al., 2018, Çiçek et al., 2016). For example, miR-221 can protect human neurons from toxicity-induced stress (Oh et al., 2018), several microRNAs have been implicated in fine-tuning the redox stress response (Cheng et al., 2013), and miR-393a enhances stress tolerance (Zhao et al., 2018). We hypothesize that microRNAs mediate NMNAT splice variant expression under stress, owing to their ability to directly influence mRNA levels post-transcriptionally. We thus seek to identify potential microRNAs that are involved in the regulation of NMNAT-mediated stress resistance.In this study, we identified dme-miR-1002, a microRNA with the ability to regulate alternative splicing by binding to NMNAT pre-mRNA and upregulating NMNAT mRNA variant RB. Furthermore, we found that miR-1002 is critical to Drosophila thermotolerance and the stress response of NMNATRB. Our findings suggest a previously unknown mode of gene expression regulation by non-coding RNAs and further reveal a new mechanism of maintaining homeostasis through stress resilience.
Results
miR-1002 Knockout Flies Have Decreased NMNAT RB and PD Expression
Drosophila melanogaster has a single Nmnat gene producing two mRNA splice variants, RA and RB, which encode protein variants PC and PD, respectively. The pre-mRNA contains seven exons, with exons 1–4 commonly spliced and exons 5–7 alternatively spliced (Figure 1A). Since the enzymatic function required for NAD+ synthesis is encoded in exons 1–4, both protein isoforms PC and PD have enzymatic activity (Ruan et al., 2015). Exon 7 encodes a nuclear localization motif; therefore, isoform PC including exons 6 and 7 is nuclear localized, whereas isoform PD including exon 5 is localized in the cytoplasm and confers robust neuroprotective function (Ruan et al., 2015).
Figure 1
miR-1002 Knockout Flies Have Decreased NMNAT RB and PD Expression
(A) Diagram showing Drosophila NMNAT pre-mRNA, mRNA splice variants, and protein isoforms. dme-miR-1002 binding sequence on DmNmnat depicted at top, with box around Box 2 sequences.
(B) NMNAT RNA levels in heads of control wild-type (yw), miR-1002 homozygous knockout (ΔmiR-1002), and rescue flies (ΔmiR-1002; UAS-miR-1002/elav-Geneswitch). Geneswitch flies were collected at 2DAE and fed RU486 for 5 days. RP49 used as reference gene. Normalized to control NMNAT RA. Bars indicate mean ± S.E.M. N = 4, One-Way ANOVA, Tukey's post hoc. *p < 0.05, **p < 0.01, ***p < 0.001.
(C) Western blot of control, ΔmiR-1002, and rescue fly heads. NMNAT PC and PD bands indicated at top. Actin loading control blot at bottom.
(D) Quantification of (C). Band intensities were normalized to actin, then control NMNAT levels set to 1. Bars indicate mean ± S.E.M. N = 4, ns, not significant; *p < 0.05, One-Way ANOVA, Tukey's post hoc.
(E) S2 cell dual luciferase activity assay. S2 cells were transfected with constructs expressing firefly luciferase linked to control wt NMNAT RB 3′UTR (RB 3′UTR control), firefly luciferase linked to NMNAT RB 3′UTR with the miR-1002 binding sequence mutated (RB 3′UTR seed mutant), or firefly luciferase only. In addition, miR-1002 or a scrambled miR-1002 control plasmid was transfected along with a Renilla luciferase plasmid. Firefly luciferase activity was normalized to Renilla luciferase activity levels, then standardized to the firefly luciferase only condition. Control + wt NMNAT RB 3′UTR was set to 1. Bars indicate mean ± S.E.M. N = 4, One-way ANOVA, Tukey's post hoc. ns, not significant.
(F) Actinomycin D chase assay. S2 cells were transfected with plasmids expressing miR-1002 or a scrambled miR-1002 control. RNA was collected at indicated time points after actinomycin D treatment, then NMNAT RB levels quantified by qPCR. Nonlinear regression was performed for NMNAT RB remaining (normalized to RP49) from initial amount at each time point. Points represent mean ± S.E.M. of N = 3 per condition per time point.
See also Figure S1.
miR-1002 Knockout Flies Have Decreased NMNATRB and PD Expression(A) Diagram showing DrosophilaNMNAT pre-mRNA, mRNA splice variants, and protein isoforms. dme-miR-1002 binding sequence on DmNmnat depicted at top, with box around Box 2 sequences.(B) NMNAT RNA levels in heads of control wild-type (yw), miR-1002 homozygous knockout (ΔmiR-1002), and rescue flies (ΔmiR-1002; UAS-miR-1002/elav-Geneswitch). Geneswitch flies were collected at 2DAE and fed RU486 for 5 days. RP49 used as reference gene. Normalized to control NMNATRA. Bars indicate mean ± S.E.M. N = 4, One-Way ANOVA, Tukey's post hoc. *p < 0.05, **p < 0.01, ***p < 0.001.(C) Western blot of control, ΔmiR-1002, and rescue fly heads. NMNAT PC and PD bands indicated at top. Actin loading control blot at bottom.(D) Quantification of (C). Band intensities were normalized to actin, then control NMNAT levels set to 1. Bars indicate mean ± S.E.M. N = 4, ns, not significant; *p < 0.05, One-Way ANOVA, Tukey's post hoc.(E) S2 cell dual luciferase activity assay. S2 cells were transfected with constructs expressing firefly luciferase linked to control wt NMNATRB 3′UTR (RB 3′UTR control), firefly luciferase linked to NMNATRB 3′UTR with the miR-1002 binding sequence mutated (RB 3′UTR seed mutant), or firefly luciferase only. In addition, miR-1002 or a scrambled miR-1002 control plasmid was transfected along with a Renilla luciferase plasmid. Firefly luciferase activity was normalized to Renilla luciferase activity levels, then standardized to the firefly luciferase only condition. Control + wt NMNATRB 3′UTR was set to 1. Bars indicate mean ± S.E.M. N = 4, One-way ANOVA, Tukey's post hoc. ns, not significant.(F) Actinomycin D chase assay. S2 cells were transfected with plasmids expressing miR-1002 or a scrambled miR-1002 control. RNA was collected at indicated time points after actinomycin D treatment, then NMNATRB levels quantified by qPCR. Nonlinear regression was performed for NMNATRB remaining (normalized to RP49) from initial amount at each time point. Points represent mean ± S.E.M. of N = 3 per condition per time point.See also Figure S1.To identify potential regulators of DrosophilaNmnat expression, we performed a putative microRNA seed sequence scan on NMNATRB 3′UTR via microRNA.org (Enright et al., 2003, John et al., 2004) and identified dme-miR-1002 among the highest scoring microRNAs (Figure 1A), with a miRSVR score of −0.5339, where miRSVR scores below −0.1 indicate high sensitivity and specificity (Betel et al., 2010).To test if miR-1002 can modulate NMNATRB levels, we obtained miR-1002 homozygous knockout flies (ΔmiR-1002) and determined mRNA levels of variant RA and RB in heads by quantitative real-time PCR (Figure 1B). We observed significantly reduced levels of NMNATRB, and increased RA, when compared with wild-type control (yw) flies. Furthermore, we found decreased NMNATPD protein (Figures 1C and 1D) in the knockout flies. When we rescued these flies by conditional overexpression of miR-1002 in the knockout background (ΔmiR-1002; elav-Geneswitch/UAS-miR-1002), we observed a significant increase in NMNATRB and a decrease in RA compared with knockout (Figure 1B). The rescue flies also had a significant increase in NMNATPD (Figures 1C and 1D). This suggests that miR-1002 is important in regulating the expression of NMNATRB mRNA and PD protein levels in vivo.
miR-1002 Shows No Effect in Altering the Stability of NMNAT RB
Reduced variant RB expression in ΔmiR-1002 suggests that miR-1002 functions to increase the expression of its target mRNA, contrary to conventional 3′UTR-mediated mRNA degradation. To elucidate the molecular mechanisms of transcriptional regulation, we first tested the role of miR-1002 in 3′UTR-mediated mRNA stability using a dual luciferase activity assay (Figure 1E). Either the wild-type NMNATRB 3′UTR sequence (RB 3′UTR control) or NMNATRB 3′UTR with the miR-1002 seed sequence mutated (RB 3′UTR seed mutant) was inserted downstream of firefly luciferase in an expression vector. This plasmid was co-transfected into DrosophilaS2 cells along with two additional plasmids: a Renilla luciferase expression plasmid (for transfection efficiency control) and either a plasmid overexpressing miR-1002 (miR-1002) or a control plasmid expressing a scrambled miR-1002 sequence (control). Forty-eight hours after transfection, we measured firefly and Renilla luciferase activity to test if miR-1002 can downregulate expression of firefly luciferase through NMNATRB 3′UTR and if its binding sequence must be left intact for this to occur. In this reporter assay, we did not observe a significant difference in luciferase activity in cells co-transfected with the miR-1002 plasmid compared with the control plasmid. The same result was observed with both the wild-type and mutant NMNAT 3′UTR luciferase plasmids. This suggests that miR-1002 does not promote 3′UTR-mediated mRNA degradation.However, it remains possible that miR-1002 can affect the stability of NMNATRB indirectly through other regulatory pathways. To examine this possibility, we performed an actinomycin D chase assay where miR-1002 or a control was overexpressed by plasmid transfection in S2 cells and the endogenous NMNATRB degradation rate was monitored after transcription was inhibited with actinomycin D (Qiu et al., 2016, Tew et al., 2014). As shown in Figure 1F, no significant difference in mRNA half-life for NMNATRB was observed between cells expressing miR-1002 and control. Collectively, these results suggest that miR-1002 does not affect the stability of NMNATRB in a 3′UTR-dependent or an indirect manner.
In Silico Analysis Reveals the miR-1002-Mediated Disruption of the Box 1-Box 2 Stem-Loop and Differential Minimum Free Energy Values in a Sequence-Specific Manner
To understand how miR-1002 affects NMNAT expression, we examined its binding sequence relative to known regulatory elements. Two key elements in intron 4 and exon 5 have previously been found to be critical for alternative splicing (Raker et al., 2009). As shown in Figure 1A, complementary sequences in intron 4 (Box 1) and exon 5 (Box 2) must bind to form a pre-mRNA stem-loop to facilitate the skipping of exon 5 and inclusion of exon 6, thus forming the RA mRNA variant. When the stem-loop is not formed, exon 5 is preferentially spliced in, producing the RB variant.The predicted binding sequence of miR-1002 overlaps Box 2 (Figure 1A, boxed nucleotides on DmNMNAT); we therefore hypothesized that miR-1002 binding to NMNAT pre-mRNA may interfere with formation of the stem-loop and shift splicing of NMNAT pre-mRNA toward RB. Furthermore, miR-1002 and NMNAT Box 2 sequences are conserved across Drosophilae (Figure S2). There is remarkable conservation of the Box 2 sequences on NMNAT which miR-1002 is predicted to bind (Figure S2A, red asterisks), and the sequence on miR-1002 that is predicted to bind them (Figure S2B, red asterisks). This highlights the evolutionary importance of these sequences in regulating NMNAT expression.To test our hypothesis, we used an in silico approach to predict the RNA secondary structure of various NMNAT and miR-1002 duplexes. In particular, we determined the RNA secondary structure of wild-type exon 4 and intron 5 of NMNAT using RNAfold of the Vienna RNA package (Lorenz et al., 2011), utilizing default parameter settings. To visualize the corresponding minimum free energy structures, we utilized the FORNA web server (Kerpedjiev et al., 2015). We used this platform to model the structural consequences of miR-1002 binding to NMNAT4−7, as well as the effects of various mutations on this interaction. As previously indicated (Raker et al., 2009), wild-type NMNAT4−7 RNA sequence forms a stem-loop structure via complementary binding of Box 1 (cyan) and Box 2 (blue), a result that we corroborate with our folding of the secondary structure of wild-type NMNAT exon 4 and intron 5 (Figure 2A). Assuming that miR-1002 binds its predicted RNA sequence in Box 2, the ability of the corresponding nucleotides to bind other nucleotides in wild-type exon 4 and intron 5 of NMNAT is restricted. Simulating such an assumption, we constrained binding of the corresponding nucleotides using RNAfold, allowing us to observe a massive disruption of the stem-loop structure (Figure 2B). The NMNAT4−7 mutations modeled in Figures 2C–2E encompass mutations within the miR-1002 binding sequence on NMNAT, precluding miR-1002 binding. When miR-1002's seed sequence outside of the binding stem is mutated (gray, mutated nucleotides in red), miR-1002 can no longer bind, allowing the stem-loop structure to form (Figure 2C). When miR-1002's binding sequence within Box 2 is mutated instead, miR-1002 binding is again impeded (Figure 2D). However, the stem-loop is expected to no longer form as a consequence of the disruption of the complementary sequences between Box 1 and Box 2. Finally, when sequences in Box 1 are mutated to be complementary to the Box 2 mutations, the stem-loop forms again (Figure 2E). However, corresponding mutations in the box 2 sequence prevent miR-1002 from binding.
Figure 2
In Silico Analysis Reveals miR-1002-Mediated Disruption of Box 1-Box 2 Stem-Loop Secondary Structure and Differential MFE Values in a Sequence-Specific Manner
(A) FORNA minimum free energy model of the secondary structure of wt exon 4 and intron 5 sequences of NMNAT confirms the emergence of a stem between Box 1 (cyan) and Box 2 (blue) subsequences.
(B) miR-1002 (yellow) binds a putative seed sequence (gray) and sequences in Box 2, disrupting the stem.
(C–E) FORNA minimum free energy models of NMNAT where red sequences indicated nucleotide scrambled mutations. (C) Scramble mutation to miR-1002 seed; (D) scramble mutation to Box 2; (E) Box 1/Box 2 scramble mutation.
(F) Minimum free energy values (kcal/mole) for various combinations of binding partners for NMNAT Box 2, calculated through duplexfold function in RNAStructure (Reuter and Mathews, 2010). Top row depicts the three NMNAT Box 2 variants used in this analysis-NMNATwt, the wild-type sequence of NMNAT Box 2 region; NMNAT1002Seed, NMNAT Box 2 with 4 nucleotides in the miR-1002 seed sequence scrambled; NMNATBox2m, 5 nucleotides in Box 2 were scrambled. The left column depicts the five binding partners used—NMNATwt, the wild-type Box 1 region; NMNATBox1m, 5 nucleotides in Box 1 mutated in a complementary manner to the NMNATBox2m mutations; miR-1002wt, the wild-type miR-1002-5p sequence; miR-1002Seed, the seed sequence of miR-1002 mutated in a complementary manner to the NMNAT1002Seed mutations; miR-1002Box2, with the Box 2 sequences on miR-1002 mutated in a complementary manner to the NMNATBox2m mutations. Box to the right of each sequence depicts MFE of duplex binding based on color.
See also Figure S2.
In Silico Analysis Reveals miR-1002-Mediated Disruption of Box 1-Box 2 Stem-Loop Secondary Structure and Differential MFE Values in a Sequence-Specific Manner(A) FORNA minimum free energy model of the secondary structure of wt exon 4 and intron 5 sequences of NMNAT confirms the emergence of a stem between Box 1 (cyan) and Box 2 (blue) subsequences.(B) miR-1002 (yellow) binds a putative seed sequence (gray) and sequences in Box 2, disrupting the stem.(C–E) FORNA minimum free energy models of NMNAT where red sequences indicated nucleotide scrambled mutations. (C) Scramble mutation to miR-1002 seed; (D) scramble mutation to Box 2; (E) Box 1/Box 2 scramble mutation.(F) Minimum free energy values (kcal/mole) for various combinations of binding partners for NMNAT Box 2, calculated through duplexfold function in RNAStructure (Reuter and Mathews, 2010). Top row depicts the three NMNAT Box 2 variants used in this analysis-NMNATwt, the wild-type sequence of NMNAT Box 2 region; NMNAT1002Seed, NMNAT Box 2 with 4 nucleotides in the miR-1002 seed sequence scrambled; NMNATBox2m, 5 nucleotides in Box 2 were scrambled. The left column depicts the five binding partners used—NMNATwt, the wild-type Box 1 region; NMNATBox1m, 5 nucleotides in Box 1 mutated in a complementary manner to the NMNATBox2m mutations; miR-1002wt, the wild-type miR-1002-5p sequence; miR-1002Seed, the seed sequence of miR-1002 mutated in a complementary manner to the NMNAT1002Seed mutations; miR-1002Box2, with the Box 2 sequences on miR-1002 mutated in a complementary manner to the NMNATBox2m mutations. Box to the right of each sequence depicts MFE of duplex binding based on color.See also Figure S2.We then probed the effects of various mutations to NMNAT and miR-1002 on the binding energy of the predicted duplex (Figure 2F). Using RNA Structure 6.1 (Reuter and Mathews, 2010), we calculated the minimum free energy of binding for various combinations of binding partners for NMNAT Box 2. The top row depicts the NMNAT exon 5 sequence used in the modeling wild-type (NMNATwt), seed scramble (NMNAT1002Seed, four nucleotides within miR-1002's seed sequence on NMNAT were scrambled to disrupt miR-1002 binding as in Figure 2C), and Box 2 scramble (NMNATBox2, five nucleotides within Box 2 were scrambled to disrupt miR-1002 binding as in Figure 2D). The left column shows the binding partners for NMNAT Box 2 used in this model. The top 2 are NMNAT Box 1 wild-type and NMNAT Box 1 scramble (NMNATBox1m, five nucleotides within Box 1 were scrambled in a complementary manner to the Box 2 scramble as in Figure 2E). The bottom three are wild-type miR-1002 (miR-1002wt), seed scramble (miR-1002Seed, four nucleotides within miR-1002's seed sequence scrambled in a complementary manner to NMNAT1002seed, so as to restore miR-1002 binding), and Box 2 scramble (miR-1002Box2, five nucleotides within miR-1002's Box 2 sequence scrambled in a complementary manner to NMNATBox2m, so as to restore miR-1002 binding).Indeed, when miR-1002's binding to NMNAT is disrupted through mutations to the binding nucleotides (NMNATwt + miR-1002Seed(10), NMNATwt + miR-1002Box2(13), NMNAT1002Seed + miR-1002wt(8), NMNAT1002Seed + miR-1002Box2(14), NMNATBox2m + miR-1002wt(9), NMNATBox2m + miR-1002wt(12)), there is a significant increase in minimum free energy (MFE), indicating a less stable structure. MFE decreases when miR-1002 is mutated in a complementary manner to restore binding to NMNAT (NMNAT1002Seed + miR-1002Seed(11), NMNATBox2m + miR-1002Box2(15)), indicating a strong and stable structure. In addition, Box 2 forming the stem-loop structure with Box 1 had low MFE values when the appropriate nucleotides were complementary (NMNATwt + NMNATwt(1), NMNAT1002Seed + NMNATwt(2), NMNATBox2m + NMNATBox1m(6)). Together, this analysis demonstrates how alternations in nucleotides have significant effects on the RNA secondary structure and binding energy and that the binding between miR-1002/Box 1 and Box 2 is direct and sequence specific.
miR-1002 Interferes with the Stem-Loop Mediated Alternative Splicing of NMNAT Pre-mRNA in a Sequence-Specific Manner
To experimentally verify our in silico modeling results, we developed a cellular reporter assay to test the functional consequences of various mutations on NMNAT splicing (Figure 3A). DrosophilaS2 cells were transfected with a reporter plasmid containing firefly luciferase cDNA and NMNAT pre-mRNA exons 4–7 driven from a UAS promoter (pUAS-luc2-NMNAT4−7). We co-transfected these cells with a plasmid expressing GAL4 and a scrambled miR-1002 sequence (pAC-GAL4-miR-1002-NegativeScramble) or wild-type miR-1002 (pAC-GAL4-miR-1002). The GAL4/UAS design ensures the co-expression of the Luc-NMNAT4−7 reporter and miR-1002-GAL4. We then extracted RNA from these cells and determined NMNAT splice variant mRNA levels by qPCR. As shown in Figure 3B, overexpression of miR-1002 along with wild-type NMNAT reporter (NMNATwt) resulted in a significant increase in RB and decrease in RA (second set of bars) when compared with control (first set of bars). This is consistent with our hypothesis that miR-1002 interferes with stem-loop formation and shifts the splicing of NMNAT pre-mRNA toward NMNATRB and away from RA. The upregulation of NMNATRB by wild-type miR-1002 was not the result of increased transcription, as the RB/RA ratio was significantly increased (Figure S3A). When miR-1002 with its seed sequence mutated (third set of bars, corresponding to Figure 2F10) or its Box 2 sequence mutated (fourth set of bars, corresponding to Figure 2F13) was co-transfected along with the wild-type reporter, there was no effect on NMNAT splicing.
Figure 3
miR-1002 Interferes with the Stem-Loop Mediated Alternative Splicing of NMNAT Pre-mRNA in a Sequence-Specific Manner
(A) Schematic representation of S2 cell splicing assay. miR-1002 (yellow) is expressed from a pAC-GAL4 vector. GAL4 protein from pAC-GAL4 activates UAS elements in a reporter construct (pUAS-Luc2-NMNAT4−7). Pre-mRNA from the reporter plasmid is then alternatively spliced into two variants. RNA is extracted from cells, then qPCR is performed for the mature NMNAT mRNA splice variants. This experiment was performed with combinations of the mutations introduced in Figure 2.
(B–E) Quantification of splicing assay. (B) wt pUASLuc-NMNAT4−7 transfected with three different PAC-GAL4-miR-1002 variants (miR-1002wt, second set of bars; miR-1002Seed, third set of bars; miR-1002Box2, fourth set of bars) and a negative control miR-1002 scramble plasmid (first set of bars). (C) pUAS-Luc2-NMNAT4−7 Seed scramble (corresponding to NMNAT1002Seed from Figure 2) transfected with two different PAC-GAL4-miR-1002 variants (miR-1002wt, second set of bars; miR-1002seed, third set of bars) and a negative control miR-1002 scramble plasmid (first set of bars). (D) pUAS-Luc2-NMNAT4−7 Box2 scramble (corresponding to NMNATBox2m in Figure 2) transfected with two different PAC-GAL4-miR-1002 variants (miR-1002wt, second set of bars; miR-1002Box2,third set of bars) and a negative control miR-1002 scramble plasmid (first set of bars). (E) pUAS-Luc2-NMNAT4−7 Box1Box2 scramble (corresponding to NMNATBox1Box2m in Figure 2) transfected with two different PAC-GAL4-miR-1002 variants (miR-1002wt, second set of bars; miR-1002Box2, third set of bars) and a negative control miR-1002 scramble plasmid (first set of bars). Bars represent mean ± S.D. transcript levels for each condition and splice variant. Data were normalized to RP49 and control RA set to 1. N > 4, One-Way ANOVA, Tukey's post hoc, ns, not significant; *p < 0.05, ***p < 0.001. ****p < 0.0001.
See also Figure S3.
miR-1002 Interferes with the Stem-Loop Mediated Alternative Splicing of NMNAT Pre-mRNA in a Sequence-Specific Manner(A) Schematic representation of S2 cell splicing assay. miR-1002 (yellow) is expressed from a pAC-GAL4 vector. GAL4 protein from pAC-GAL4 activates UAS elements in a reporter construct (pUAS-Luc2-NMNAT4−7). Pre-mRNA from the reporter plasmid is then alternatively spliced into two variants. RNA is extracted from cells, then qPCR is performed for the mature NMNAT mRNA splice variants. This experiment was performed with combinations of the mutations introduced in Figure 2.(B–E) Quantification of splicing assay. (B) wt pUASLuc-NMNAT4−7 transfected with three different PAC-GAL4-miR-1002 variants (miR-1002wt, second set of bars; miR-1002Seed, third set of bars; miR-1002Box2, fourth set of bars) and a negative control miR-1002 scramble plasmid (first set of bars). (C) pUAS-Luc2-NMNAT4−7 Seed scramble (corresponding to NMNAT1002Seed from Figure 2) transfected with two different PAC-GAL4-miR-1002 variants (miR-1002wt, second set of bars; miR-1002seed, third set of bars) and a negative control miR-1002 scramble plasmid (first set of bars). (D) pUAS-Luc2-NMNAT4−7 Box2 scramble (corresponding to NMNATBox2m in Figure 2) transfected with two different PAC-GAL4-miR-1002 variants (miR-1002wt, second set of bars; miR-1002Box2,third set of bars) and a negative control miR-1002 scramble plasmid (first set of bars). (E) pUAS-Luc2-NMNAT4−7 Box1Box2 scramble (corresponding to NMNATBox1Box2m in Figure 2) transfected with two different PAC-GAL4-miR-1002 variants (miR-1002wt, second set of bars; miR-1002Box2, third set of bars) and a negative control miR-1002 scramble plasmid (first set of bars). Bars represent mean ± S.D. transcript levels for each condition and splice variant. Data were normalized to RP49 and control RA set to 1. N > 4, One-Way ANOVA, Tukey's post hoc, ns, not significant; *p < 0.05, ***p < 0.001. ****p < 0.0001.See also Figure S3.To determine the sequence specificity of miR-1002 in regulating NMNAT alternative splicing, we tested the mutations modeled in Figure 2. As shown in Figure 3C, when the miR-1002 seed sequence outside of NMNAT Box 2 was mutated such that wild-type miR-1002 could no longer bind as in Figure 2C (NMNAT1002Seed), miR-1002 overexpression had no effect on RB expression (second set of bars, corresponding to Figure 2F8). This suggests that miR-1002 binding to its seed sequence is required for its effect on splicing. When miR-1002 itself was mutated in a complementary manner to restore binding, we observed a restoration of the downregulation in RA and upregulation in RB (far right bars, corresponding to Figure 2F11). Seed-mutated miR-1002 also increased the RB/RA ratio significantly (Figure S3B).In contrast, when miR-1002's binding sequence within Box 2 was mutated to disrupt both stem-loop formation and miR-1002 binding as in Figure 2D (NMNATBox2m), there was no change in NMNAT variant expression in response to miR-1002 overexpression (Figure 3D). This was true with both wild-type miR-1002 (second set of bars) and miR-1002 with complementary mutations to NMNAT's Box 2 mutations to restore binding (third set of bars, corresponding to Figure 2F15). Additionally, the RB levels and RB/RA ratio (Figure S3C) for all conditions increased relative to the control wild-type Nmnat4−7 plasmid, as the disruption of stem-loop results in exon 5 inclusion to produce RB. This further confirms the validity of our reporter system in assessing stem-loop formation.Finally, when sequences in Box 1 were mutated in a complementary manner to the Box 2 mutations as in Figure 2E (NMNATBox1Box2m), RB levels decreased (Figure 3E) and the RB/RA ratio decreased (Figure S3D). This was expected since the complementary sequences of Box 1 and Box 2 allow the formation of the stem-loop and the exclusion of exon 5 to form RA. Although wild-type miR-1002 could not significantly alter NMNAT alternative splicing compared with control owing to its inability to bind NMNAT (first and second set of bars, corresponding to Figure 2F9), miR-1002 with a complementary Box 2 mutation was able to upregulate RB and downregulate RA (third set of bars, corresponding to Figure 2F15). With miR-1002 able to bind to NMNAT again, it could compete with Box 1 for binding to Box 2 and increase the RB/RA splicing ratio (Figure S3D). Collectively, these results show that miR-1002 binding is necessary and sufficient to interfere with the stem-loop formation and shifts the splicing of NMNAT pre-mRNA to NMNATRB.
miR-1002 Promotes the Inclusion of the RB-Exclusive Fifth Exon in an In Vivo Neuronal NMNAT Alternative Splicing Reporter
To assess if miR-1002 regulates the splicing of NMNAT pre-mRNA in vivo, we utilized a previously described alternative splicing reporter (Ruan et al., 2015), where the expression of AcGFP and DsRed are used as proxies for NMNATRA and RB, respectively (Figure 4A). This is due to an in-frame AcGFP in the sixth exon and DsRed in the fifth exon.
Figure 4
miR-1002 Promotes the Inclusion of the RB-exclusive Fifth Exon in an In Vivo Neuronal NMNAT Alternative Splicing Reporter Model
(A) Schematic representation of NMNAT reporter (UAS-NMNATAltReport) (Ruan et al., 2015). Genomic NMNAT at top with miR-1002 binding sequence indicated with white triangle. NMNAT alternative splicing reporter in middle, includes dsRed (Red R) in the fifth exon and AcGFP (Green G) in the sixth exon. Mature mRNA at bottom indicates RA-like splice variant with AcGFP, and RB-like variant with dsRed.
(B) Confocal images of fly brains expressing NMNAT reporter and miR-1002, control (Luciferase), or miR-9a. Scale bar, 50 μm.
(C and D) Quantification of (B). Bars represent mean of three midbrain areas per genotype ±S.E.M, normalized to control. N = 3, One-way ANOVA, Tukey's post hoc, *p < 0.05, **p < 0.01.
miR-1002 Promotes the Inclusion of the RB-exclusive Fifth Exon in an In Vivo Neuronal NMNAT Alternative Splicing Reporter Model(A) Schematic representation of NMNAT reporter (UAS-NMNATAltReport) (Ruan et al., 2015). Genomic NMNAT at top with miR-1002 binding sequence indicated with white triangle. NMNAT alternative splicing reporter in middle, includes dsRed (Red R) in the fifth exon and AcGFP (Green G) in the sixth exon. Mature mRNA at bottom indicates RA-like splice variant with AcGFP, and RB-like variant with dsRed.(B) Confocal images of fly brains expressing NMNAT reporter and miR-1002, control (Luciferase), or miR-9a. Scale bar, 50 μm.(C and D) Quantification of (B). Bars represent mean of three midbrain areas per genotype ±S.E.M, normalized to control. N = 3, One-way ANOVA, Tukey's post hoc, *p < 0.05, **p < 0.01.Pan-neuronal overexpression of miR-1002 in the brain resulted in early lethality (data not shown). To overcome the lethality, we used an inducible Gene-switch (GS) driver (elav-GS-GAL4) to activate expression in adult flies. RU486 (Mifepristone) feeding for 5 days induced expression of the alternative splicing reporter (UAS-NMNATAltReport) along with either miR-1002 (UAS-miR-1002), a non-targeting control microRNA miR-9a (UAS-miR-9a), or negative control luciferase (UAS-Luc). AcGFP and DsRed fluorescence in the fly brain was imaged and quantitated. As shown in Figure 4B, we observed a significantly higher DsRed and lower AcGFP fluorescence in the fly brain overexpressing miR-1002 when compared with controls (Figures 4C and 4D), indicating that miR-1002 overexpression promoted the inclusion of the fifth exon of the NMNATAltReport splicing reporter construct. These results suggest that miR-1002 overexpression shifts the splicing of NMNAT pre-mRNA toward variant RB in neurons in vivo.
miR-1002 Mediates NMNAT Upregulation under Stress
NMNAT has been shown to protect many species against a variety of stresses, including heat, hypoxic, oxidative, proteotoxic, and aging stresses (Ali et al., 2012, Liu et al., 2018, Miwa et al., 2017, Rossi et al., 2018, Ruan et al., 2015, Zhou et al., 2016). Furthermore, it has previously been reported that NMNAT is a stress response gene regulated by the stress transcription factor HSF (Ali et al., 2011). Neuronal NMNATPD protein and NMNATRB mRNA, but not NMNATRA, are upregulated in response to heat stress (Ruan et al., 2015). This demonstrates a stress-induced splicing “switch” to RB to confer increased protection. However, the mechanism of the variant-specific stress response “switch” to RB is unknown. miR-1002 presents an excellent candidate for this “switch” since it can bind to NMNAT pre-mRNA to obstruct the stem-loop formation and shift the splicing of NMNAT pre-mRNA into NMNATRB. In addition, it has been reported that miR-1002 is upregulated in response to heat shock (Funikov et al., 2016) and oxidative stress induced by the treatment of a carcinogenic chemical Cr(VI) (Chandra et al., 2015). We wanted to investigate if the exclusive upregulation of NMNATRB in these stress conditions is a result of miR-1002 enhancing the splicing of NMNAT pre-mRNA into RB. We subjected wild-type control yw and ΔmiR-1002 flies to heat shock at 37°C for 45 min, a stress paradigm that has been shown to induce the highest level of NMNATRB upregulation (Ruan et al., 2015). As expected, wild-type flies exhibited a significant upregulation in NMNATRB but no significant change to RA in response to heat shock, whereas ΔmiR-1002 flies lacked the increase in NMNATRB in response to heat shock (Figure 5A). Moreover, there was a significant upregulation in NMNATRA in the heat-shocked ΔmiR-1002 flies. This supports a model in which NMNAT pre-mRNA transcription is increased during heat stress by heat shock transcription factor HSF, and the pre-mRNA is spliced almost exclusively to NMNATRB owing to increased miR-1002. In the absence of miR-1002, the pre-mRNA is preferentially spliced into RA because of the structurally stable (low MFE) stem-loop formation.
Figure 5
miR-1002 Is Critical for Thermotolerance and the Upregulation of NMNAT RB under Heat Stress
(A) NMNAT RA and RB levels in control wild-type yw and ΔmiR-1002 flies before and after heat shock. After NMNAT variant expression levels were normalized to RP49, control RB was set to 1. Bars represent mean ±S.E.M. N = 7 for baseline, N = 4 for heat stress. One-way ANOVA, Tukey's post hoc, *p < 0.05, **p < 0.01, ****p < 0.0001.
(B) Thermotolerance assay of control and ΔmiR-1002 flies. Flies were subjected to heat shock and time taken to paralysis was recorded. Data points represent mean percent active flies at that time point. N > 200 flies, Log rank test. p = 0.0031.
(C) miR-1002 levels in heat shock. Wild-type flies were subjected to heat shock, and miR-1002 levels in heads quantified via qPCR and normalized to RP49 levels. Bars represent mean ±S.E.M. N=4, One-way ANOVA, Tukey's post hoc, *p < 0.05.
miR-1002 Is Critical for Thermotolerance and the Upregulation of NMNATRB under Heat Stress(A) NMNATRA and RB levels in control wild-type yw and ΔmiR-1002 flies before and after heat shock. After NMNAT variant expression levels were normalized to RP49, control RB was set to 1. Bars represent mean ±S.E.M. N = 7 for baseline, N = 4 for heat stress. One-way ANOVA, Tukey's post hoc, *p < 0.05, **p < 0.01, ****p < 0.0001.(B) Thermotolerance assay of control and ΔmiR-1002 flies. Flies were subjected to heat shock and time taken to paralysis was recorded. Data points represent mean percent active flies at that time point. N > 200 flies, Log rank test. p = 0.0031.(C) miR-1002 levels in heat shock. Wild-type flies were subjected to heat shock, and miR-1002 levels in heads quantified via qPCR and normalized to RP49 levels. Bars represent mean ±S.E.M. N=4, One-way ANOVA, Tukey's post hoc, *p < 0.05.To assess the functional effects of miR-1002 in stress response, we performed a thermotolerance assay whereby flies are subjected to a heat preconditioning (35°C for 30 min) followed by an extreme heat shock at 39°C, and the time to paralysis is recorded. It has been shown that loss of NMNAT leads to reduced latency to paralysis and that NMNAT overexpression confers paralysis resistance (Ali et al., 2011). As shown in Figure 5B, ΔmiR-1002 flies had a reduced latency to paralysis compared with wild-type flies (p = 0.0031). The median survival time for control and ΔmiR-1002 were 60 and 50 min, respectively. At 50 min, 54.086% of control flies remained active, compared with 41.154% of knockout flies. This suggests that miR-1002 is critical for thermotolerance and enhances stress resistance in part though upregulating NMNATRB as one of the key targets in the stress response network.To determine if miR-1002 is upregulated during heat stress, we extracted the small RNA pool from wild-type fly heads after 15 and 45 min of heat shock. We detected a significant increase in miR-1002 level at both time points (Figure 5C). This demonstrates that miR-1002 is a heat-responsive microRNA and its increased transcription correlates with increased NMNAT splicing to RB. Higher levels of miR-1002 binding to NMNAT pre-mRNA facilitated efficient splicing to RB under stress.
Argonaute 1 Plays a Significant Role in miR-1002 Regulation of NMNAT Splicing
It has been well characterized that during RISC formation, mature Drosophila microRNAs are typically loaded onto Argonaute 1 before binding to target transcripts (Förstemann et al., 2007, Pushpavalli et al., 2012). We sought to determine the role of Argonaute 1 in miR-1002-mediated regulation of NMNAT splicing. We obtained Argonaute 1 hemizygous (AGO1) mutant flies, which had previously been shown to have significantly reduced Argonaute 1 levels (Pushpavalli et al., 2014). Heat stress treatment of AGO1 flies resulted in no significant changes to RA or RB levels (Figure 6A), suggesting that Argonaute 1 is crucial to NMNAT's stress response.
Figure 6
Argonaute 1 Is Required for miR-1002-Mediated NMNAT Regulation
(A) NMNAT splice variant expression in response to heat shock in AGO1 hemizygous mutant flies. Flies were subjected to 45 min of heat shock at 37°C before RNA was extracted for qPCR. NMNAT levels normalized to RP49. No HS RA was set to 1. Bars represent as mean ± S.E.M. N = 4. One-way ANOVA, Tukey's post hoc.
(B) NMNAT splice variants in miR-1002 overexpression flies. Control flies expressing LacZ from an elav-geneswitch promoter, flies expressing miR-1002, and flies expressing miR-1002 in an AGO1 hemizygous mutant background were fed RU486 for 5 days, then RNA extracted from heads. NMNAT splice variant levels were normalized to RP49. Control RA was set to 1. Bars represent mean ±S.E.M. N=4, One-way ANOVA, Tukey's post hoc, ns, not significant; **p < 0.01, ***p < 0.001.
(C) Western blot of S2 cell fractions before and after heat shock. S2 cells were subjected to 1 h of heat shock at 37°C, then lysed to purify subcellular fractions. Total cell input, cytoplasm, and nuclei fractions were run together, then blotted for AGO1, Histone H1 (nuclear marker), Calreticulin (ER marker), and α-Tubulin (cytoplasmic marker).
(D) Quantification of (C). Band intensities of AGO1 were normalized to Tubulin for the total cell and cytoplasmic fractions, and Histone for the nucleic fractions. Approximately 6 × 104 cells loaded into each whole-cell lane, ∼1 × 105 cells worth of cytoplasm in each cytoplasm lane, and ∼3 × 105 nuclei loaded into the nuclei lanes. Each fraction was normalized to its no HS condition. Bars represent mean ±S.E.M. N = 4 One-way ANOVA, Tukey's post hoc, **p < 0.01.
(E) S2 cells were subjected to 1 h of heat shock at 37°C, then stained for DAPI and AGO1. Confocal microscopy was used to image and measure AGO1 in nuclei.
(F) Quantification of (E). 1–3 are 3 different experiments, with box plot for all experiments combined. Each dot represents a different cell. At least 140 cells were counted for each condition. Box represents upper quartile to lower quartile, with line to represent median. Whiskers represent 5 and 95 percentiles. Student's t test, ****p < 0.0001.
See also Figure S4.
Argonaute 1 Is Required for miR-1002-Mediated NMNAT Regulation(A) NMNAT splice variant expression in response to heat shock in AGO1 hemizygous mutant flies. Flies were subjected to 45 min of heat shock at 37°C before RNA was extracted for qPCR. NMNAT levels normalized to RP49. No HS RA was set to 1. Bars represent as mean ± S.E.M. N = 4. One-way ANOVA, Tukey's post hoc.(B) NMNAT splice variants in miR-1002 overexpression flies. Control flies expressing LacZ from an elav-geneswitch promoter, flies expressing miR-1002, and flies expressing miR-1002 in an AGO1 hemizygous mutant background were fed RU486 for 5 days, then RNA extracted from heads. NMNAT splice variant levels were normalized to RP49. Control RA was set to 1. Bars represent mean ±S.E.M. N=4, One-way ANOVA, Tukey's post hoc, ns, not significant; **p < 0.01, ***p < 0.001.(C) Western blot of S2 cell fractions before and after heat shock. S2 cells were subjected to 1 h of heat shock at 37°C, then lysed to purify subcellular fractions. Total cell input, cytoplasm, and nuclei fractions were run together, then blotted for AGO1, Histone H1 (nuclear marker), Calreticulin (ER marker), and α-Tubulin (cytoplasmic marker).(D) Quantification of (C). Band intensities of AGO1 were normalized to Tubulin for the total cell and cytoplasmic fractions, and Histone for the nucleic fractions. Approximately 6 × 104 cells loaded into each whole-cell lane, ∼1 × 105 cells worth of cytoplasm in each cytoplasm lane, and ∼3 × 105 nuclei loaded into the nuclei lanes. Each fraction was normalized to its no HS condition. Bars represent mean ±S.E.M. N = 4 One-way ANOVA, Tukey's post hoc, **p < 0.01.(E) S2 cells were subjected to 1 h of heat shock at 37°C, then stained for DAPI and AGO1. Confocal microscopy was used to image and measure AGO1 in nuclei.(F) Quantification of (E). 1–3 are 3 different experiments, with box plot for all experiments combined. Each dot represents a different cell. At least 140 cells were counted for each condition. Box represents upper quartile to lower quartile, with line to represent median. Whiskers represent 5 and 95 percentiles. Student's t test, ****p < 0.0001.See also Figure S4.The upregulation of NMNATRB upon stress can be recapitulated by miR-1002 overexpression. A conditional overexpression of miR-1002 in fly brains resulted in a significant increase in NMNATRB when compared with control LacZ overexpression (Figure 6B). In contrast, when miR-1002 was overexpressed in the AGO1 background, we observed an abrogation of the NMNATRB upregulation. This substantiates the essential role of Argonaute 1 in miR-1002 regulation of splicing.Since most splicing occurs co-transcriptionally in the nucleus (Carrillo Oesterreich et al., 2010), it is likely that AGO1-mediated miR-1002 regulation of splicing occurs in the nucleus. To investigate this possibility, we performed subcellular fractionation of S2 cells before and after heat shock to probe the nuclear, cytoplasmic, and whole-cell fractions for Argonaute 1, α-Tubulin (cytoplasmic marker), Calreticulin (ER marker [Gagnon et al., 2014]), and Histone H1 (nuclear marker) (Figures 6C and 6D). Argonaute 1 was present in the nuclear fraction (Figure 6C), and it was significantly increased in the nucleus after heat shock (Figure 6D). The lack of tubulin and calreticulin staining in the nuclear lanes indicates that there is no contamination from cytoplasmic or ER AGO1 in those fractions. To further validate this finding, we performed immunostaining on S2 cells before and after heat shock. As shown in Figures 6E and 6F, although the majority of Argonaute 1 protein was present in the cytoplasm under normal conditions, nuclear Argonaute 1 was significantly increased after heat shock. Additionally, we performed FISH for miR-1002 in S2 cells (Figure S4). We observed specific signal from the miR-1002 anti-sense probe in the nucleus of S2 cells, which suggests that miR-1002 can localize to the nucleus (Figure S4B). However, we did not observe significant change in miR-1002 FISH signals with heat shock. Thus, the stress-mediated localization of miR-1002 to the nucleus requires further analysis to confirm. Collectively, these results provide evidence for the potential role of Argonaute 1 in the stress-induced nuclear activity of miR-1002 and splicing of NMNAT.
Discussion
In this study, we discovered a ground-breaking mechanism of a microRNA regulating gene expression under stress. Our results demonstrate that microRNA miR-1002 regulates NMNAT variant-specific expression by interfering with the fourth intron-fifth exon stem-loop formation required for pre-mRNA alternative splicing in a direct, sequence-specific manner, rather than by the canonical 3′UTR-mediated mRNA degradation. Additionally, we found that miR-1002 and RISC component Argonaute 1 are critical for NMNAT-mediated neuronal stress resistance.
A New Role for microRNAs in Transcriptional Regulation—MIMOSAS
This new mechanism of gene regulation, which we term MIMOSAS (MIcroRNA-Mediated Obstruction of Stem-loop Alternative Splicing) (Figure 7), presents a potential new layer through which cells can specifically control the expression of transcript variants. Although microRNAs are mostly studied in the context of mature mRNA 3′UTR binding and target transcript downregulation, MIMOSAS predicts the binding of microRNAs to interior intronic or exonic regions in the pre-mRNA of targets to regulate mRNA splicing. The outcome of such microRNA-pre-mRNA duplex binding allows mRNA expression modulation in an efficient and splice variant-specific manner. Importantly, MIMOSAS not only extends the functional repertoire of microRNAs, but also adds an exciting, novel example of long-range splicing and RNA secondary structure regulation (Gueroussov et al., 2017, Raker et al., 2009).
Figure 7
MIMOSAS, a Model for miR-1002 Regulation of NMNAT Splicing
Under basal conditions (left), NMNAT is preferentially spliced into the RA mRNA variant through stem-loop formation. Under stress (right), HSF upregulates transcription of NMNAT pre-mRNA. miR-1002 is also upregulated under stress, and miR-1002 enhances the splicing of NMNAT into the RB variant by preventing formation of the stem-loop. This upregulation serves as a stress-induced “switch” to increase protection through NMNAT PD.
MIMOSAS, a Model for miR-1002 Regulation of NMNAT SplicingUnder basal conditions (left), NMNAT is preferentially spliced into the RA mRNA variant through stem-loop formation. Under stress (right), HSF upregulates transcription of NMNAT pre-mRNA. miR-1002 is also upregulated under stress, and miR-1002 enhances the splicing of NMNAT into the RB variant by preventing formation of the stem-loop. This upregulation serves as a stress-induced “switch” to increase protection through NMNATPD.Previous studies have suggested that non-coding RNAs can affect splicing. Gonzalez, et al. showed that a long non-coding RNAs (lncRNA) can promote the retention of a particular exon in FGFR2 alternative splicing (Gonzalez et al., 2015). Double-stranded RNAs can affect the splicing of genes associated with muscular dystrophy (Liu et al., 2012). A small nuclear RNA has been found to regulate the splicing of Serotonin Receptor IIC, which is associated with Prader-Willi Syndrome (Kishore and Stamm, 2006).miR-1002's ability to regulate splicing of a target transcript offers new insight to how microRNAs control gene expression. It remains to be seen how prevalent this mechanism is and whether it is conserved. It was previously reported that 42.6% of microRNA target sites in human T-REx 293 cells were found in mRNA CDS regions (Helwak et al., 2013). A study mapping Kaposi sarcoma-associated herpesvirus microRNA binding sites in B cell lymphoma-derived cells and epithelial cells found that a majority of microRNA target sites were found within the CDS of mRNAs, not the 3′UTR (Gay et al., 2018). Given that approximately 95% of multi-exonic human genes are alternatively spliced (Kim et al., 2018), microRNA target sites in the exonic and intronic regions present ample opportunities for microRNAs to target and influence pre-mRNA splicing.Our findings suggest that MIMOSAS through miR-1002 is mediated by Argonaute 1. Since most splicing occurs co-transcriptionally (Oesterreich et al., 2016), the nucleus is the most likely location for such microRNA-mediated regulation. Supporting this hypothesis is the detection of microRNAs in the nucleus. RNALocate lists over 200 examples of experimentally determined nuclear non-coding RNAs in neuronal or neuron-like cells (Zhang et al., 2017). On the other hand, Argonautes have also been shown to be localized to the nucleus and bind chromatin (Cernilogar et al., 2011, Huang and Li, 2014, Huang et al., 2013, Pushpavalli et al., 2012, Taliaferro et al., 2013). For example, Argonaute has been found to be nuclear localized in many cell types, including T47D (Chu et al., 2010), 10G, ER293 (Ohrt et al., 2008), HEK293, HeLa, and RPE-1 cells (Rüdel et al., 2008). Our study detected Argonaute1 in the nuclear fraction, further supporting the notion that microRNA regulation of splicing may occur in the nuclear compartment. Specifically, our observation of the dependence of miR-1002 on Argonaute 1 and the stress-induced nuclear enrichment of Argonaute 1 supports a model in which Argonaute 1-miR-1002 localization to the nucleus during stress conditions facilitates the splicing of NMNAT pre-mRNA into the RB variant under stress.
MicroRNA miR-1002 Is a Part of the Stress Response Network
Our previous study has found that, under stress, the NMNATRB variant is upregulated to produce the neuroprotective protein isoform (PD). Therefore, alternative splicing of NMNAT functions as a switch to enhance neuroprotection under stress (Ruan et al., 2015). Excitingly, we discovered microRNA miR-1002 as the main driver of the “switch,” as the upregulation of NMNATRB under stress is eliminated in ΔmiR-1002 flies (Figure 5A). Specifically, the observation that the heat shock upregulation of NMNATRA in ΔmiR-1002 flies mirrored the NMNATRB increase in wild-type flies suggests that miR-1002 efficiently disrupts stem-loop and pushes all newly transcribed pre-mRNA into RB under stress. Without miR-1002, the newly transcribed NMNAT pre-mRNA was almost exclusively spliced to RA.Our model predicts a novel role for miR-1002's regulation of NMNAT (Figure 7). In basal conditions, NMNAT pre-mRNA is spliced to RA with a slight preference via stem-loop formation (Ruan et al., 2015). Under stress, miR-1002 is upregulated and switches the splicing of newly transcribed NMNAT pre-mRNA almost exclusively to RB. Given the robust neuroprotective function of NMNAT isoform PD, miR-1002-mediated switch of alternative splicing enhances neuronal resistance to stress and confers organismal resilience. This is supported by the reduced thermotolerance observed in ΔmiR-1002 flies. The modest reduction in thermotolerance suggests that miR-1002 is just one of the key players in the complex stress response network. Many other genes and proteins, including heat shock proteins, have been found to contribute to stress resistance (Bartelt-Kirbach et al., 2016, Jo et al., 2017, Kawasaki et al., 2016, Morrow et al., 2016, Shukla et al., 2014). Importantly, our study found that overexpression of miR-1002 in neurons was sufficient to shift alternative splicing toward RB in vivo, further substantiating the role of miR-1002 in enhancing NMNAT-mediated neuroprotection.Our discovery of a novel mechanism of a microRNA regulating gene expression under stress unveils regulation of gene expression by noncoding RNAs in a state-specific manner and underscores the importance in considering alternative splicing modulation as therapeutic means. As 60% of point mutations associated with diseases have been found to be related to splicing defects (Jensen et al., 2009), several methods have been developed to modify alternative splicing. For example, duplex RNAs have also been used to modify alternative splicing in mammalian cells (Liu et al., 2012), and a method of using single-stranded siRNAs has been developed to modify the splicing of a Dystrophin RNA, which is associated with Duchenne muscular dystrophy (Liu et al., 2015). The results of our work introduce the possibility of microRNAs as tools to modulating alternative splicing. Although more work is required to identify other microRNA and target mRNA pairs, our work shows a promising new direction for conferring neuroprotection and organismal resilience.
Limitations of the Study
Although our data confirm the functional outcome, the mechanistic details of miR-1002 splicing regulation remain elusive. Furthermore, more work is needed to determine if this process is conserved in mammals and how prevalent the regulation of pre-mRNA splicing by microRNAs is.
Methods
All methods can be found in the accompanying Transparent Methods supplemental file.
Authors: Roel Bijkerk; Christiane Trimpert; Coen van Solingen; Ruben G de Bruin; Barend W Florijn; Sander Kooijman; Rosa van den Berg; Eric P van der Veer; Edwin O W Bredewold; Patrick C N Rensen; Ton J Rabelink; Benjamin D Humphreys; Peter M T Deen; Anton Jan van Zonneveld Journal: Am J Physiol Renal Physiol Date: 2018-05-30
Authors: Hyo Sang Jo; Dae Won Kim; Min Jea Shin; Su Bin Cho; Jung Hwan Park; Chi Hern Lee; Eun Ji Yeo; Yeon Joo Choi; Hyeon Ji Yeo; Eun Jeong Sohn; Ora Son; Sung-Woo Cho; Duk-Soo Kim; Yeon Hee Yu; Keun Wook Lee; Jinseu Park; Won Sik Eum; Soo Young Choi Journal: Mol Brain Date: 2017-01-04 Impact factor: 4.041